¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"point outside field"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • near point
    ±ÙÁ¡
  • nodal point
    ±³Á¡, °áÀýÁ¡
  • null point
    Á¤ÁöÁ¡
  • ossification point
    »ÀµÇ±âÁß½É, °ñÈ­Áß½É
  • point
    Á¡
  • point charge
    Á¡ÇÏÀü
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • point prevalence
    ½ÃÁ¡À¯º´·ü
  • point sampling
    1. Á¡ÃßÃâ(¹ý) 2. Á¡Ç¥Áý
  • reference point
    ±âÁØÁ¡
  • saturation point
    Æ÷È­Á¡
  • tender point
    ¾ÐÅëÁ¡, ´©¸§ÅëÁ¡
  • working point
    ÀÛ¿ëÁ¡
  • auditory field
    û°¢¹üÀ§, û¿ª
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lacrimal point
    ´«¹°Á¡
  • leak-point pressure
    ´©ÃâÁ¡¾Ð
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • malar point
    ±¤´ëÁ¡
  • melting point
    ³ì´ÂÁ¡
  • mental point
    (¢¡gnathion) Åγ¡À¶±âÁ¡
  • motor point
    ¿îµ¿Á¡
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • near point
    ±ÙÁ¡
  • nodal point
    ±³Á¡, °áÀýÁ¡
  • null point
    Á¤ÁöÁ¡
  • ossification point
    (¢¡ossification center) »ÀµÇ±âÁß½É, °ñÈ­Áß½É
  • point
    Á¡
  • point prevalence
    ½ÃÁ¡À¯º´À²
  • point sampling
    Á¡ÃßÃâ¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gingival point angle
    Ä¡°æÃ·°¢(öÍ ôÓÊÇ).
  • gluteal point
    µÐ Á¡.
  • gold point
    ±ÝÀÀ°íÁ¡(ÐÝëêͳïÇ).
  • halting point
    Á¤ÁöÁ¡(ïÎò­ïÇ).
  • heat rigor point
    ¿­°æÁ÷Á¡(¡­ïÇ).
  • heat rigor point
    ¿­°æÁ÷Á¡(ÊÙËø).
  • ice point
    ºùÁ¡(Ë×Ëø).
  • iliac point
    Àå°ñÁ¡.
  • incisal point angle
    Àý´Ü¿¬Ã·°¢(ôîÓ®æÞôÓÊÇ).
  • indifferent point
    Á߸³Á¡(ñéí¡ïÇ).
  • physiological zero point
    »ý¸®Àû ¿µÁ¡ (¡­çÍïÇ).
  • point angle
    Á¡°¢(ïÇÊÇ), ÷°¢(ôÓÊÇ).
  • point charge
    Á¡ÇÏÀü(ïÇùÃï³).
  • point counter
    ÷´Ü°è¼ö°ü(̧ËÀË­ËàË´).
  • point discharge
    Á¡¹æÀü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • field
    Çʵå, Ç׸ñ
  • field
    ¾ß(Ëâ), ¿µ¿ª(ËçËç), ºÎÀ§, ÇöÁö.
  • field block
    ÁÖÀ§Ä§À±¸¶Ãë(¹ý)(ñ²êÌöÙëÈØ«ö­ Ûö), ºÎÀ§Â÷´Ü, ÁÖÀ§Â÷´Ü.
  • field defect
    ½Ã¾ß°á¼Õ
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field flattening filter
    Á¶»ç¿µ¿ª ÆíÆòÈ­¿©°ú±â
  • field gradient
    ÀÚÀå °æ»ç
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ(¼º)
  • field of Cohnheim
  • field of Forel
  • field of cornu ammonis
  • field of fixation
    Áֽýþß
  • field of gaze
    Áֽþȿ¹üÀ§
  • field of view
    ½Ã¾ß (ãÊå¯)
  • field of view (FOV)
    ¿µ»ó ¿µ¿ª, ¿µ»ó ¹üÀ§
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • initiation point
    °³½ÃÁ¡(ËÒã·ïÇ)
  • isoelectric point
    µîÀüÁ¡(Ôõï³ïÇ)
  • isoelectrophoretic point
    µîÀü Àü±â¿µµ¿Á¡(Ôõï³ï³Ñ¨ç¶ÔÑïÇ)
  • isoionic point
    µî(Ôõ)À̿ Á¡(ïÇ)
  • isoprotic point
    µî¾çÀÚ Á¡(ÔõåÕí­ïÇ)
  • isosbestic point
    µîÈí±¤Á¡(ÔõýåÎÃïÇ)
  • light compensation point
    ±¤ º¸»óÁ¡(ÎÃÜÍßÁïÃ)
  • melting point
    À¶ÇØÁ¡(ë×ú°ïÆ)
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
  • point quenching
    Á¡¼ÒÆÎ(ïÃá¼ÎÃ)
  • point symmetry
    Á¡´ëĪ(ïÃÓßöà)
  • restriction point
    Á¦ÇÑÁ¡(ð¤ùÚïÃ)
  • R point
    (å²) Restriction point
  • thermal death point
    ¿­»çÁ¡(æðÞÝïÃ)
  • thermal inactivation point
    ¿­ºÒȰ¼ºÈ­Á¡ (æðÝÕüÀàõûùïÃ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • irradiation field
    ¹æ»ç¼±Á¶»ç¾ß
  • low field MR scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • lung field
    Æó¾ß
  • magnet field homogeneity
    ÀÚÀå±ÕÁú¼º
  • magnetic field
    ÀÚ(±â)Àå
  • magnetic field gradient
    ÀÚÀå°æ»ç
  • magnetic field gradient vector
    ÀÚÀå°æ»çº¤ÅÍ
  • magnetic field intensity
    ÀÚÀå°­µµ
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • magnetic fringe field
    ÀÚ±âÁÖº¯ÀÚÀå
  • magnetic induction field
    ÀÚ±âÀ¯µµÀÚÀå
  • main magnetic field inhomogenity
    ÁÖÀÚÀåºñ±ÕÁú¼º
  • middle lung field
    Á߯ó¾ß
  • near field
    ±Ù¿ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TP temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t...
HPF, hpf High Power Field; °í¹èÀ² ½Ã¾ß
LPF, lpf Low Power Field; Àú¹èÀ²½Ã¾ß
VF   1) Ventricular Fibrillation
    ? Tx of Ventricular Fibrillation ...
Vf   1) Ventricular flutter
  2) Visual field
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PRESS Point resolved spectroscopy
RIP Repeat Induced Point mutation
tsp Transcription start point
tsp Transcriptional start point
2-PD Two-point discrimination
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mastication field
    ÀúÀÛ ¿ª
  • microscopic field
    Çö¹Ì°æÀû ½Ã¾ß
  • middle lung field
    Áß Æó ¾ß
  • on center receptive field
    Áß½ÉÇü ¼ö¿ë¾ß
  • order dark field
    ±ÔÄ¢ÀûÀ¸·Î ¾îµÎ¿î ºÎÀ§
  • paddy field dermatitis
    ¼ö´ä¼º ÇǺο°
    ¼ö´ä
  • peripheral field
    ¸»ÃÊ ¿µ¿ª
  • peripheral inhibitory field
    ¸»ÃÊ ¾ïÁ¦¾ß
  • radio-frequency field
    °íÁÖÆÄ ÀÚÀå
  • receptive field organization
    ¼ö¿ë ¿µ¿ª Á¶Á÷È­
  • resorptive field
    Èí¼ö¾ß
  • sound field
    À½¿ª
  • static field
    Á¤ÀÚÀå
  • static magnetic field
    Á¤ÀÚÀå
  • super high field MR scanner
    ÃʰíÀÚÀå MR ½ºÄ³³Ê, Ãʰí ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
pulse-field gel electrophoresis Gel electrophoresis in which, after electrophoretic migration has begun, the current is briefly stopped and reapplied in a different orientation; allows for the purification of long DNA molecules.
Synonym: pulsed-field gel electrophoresis.
(05 Mar 2000)
nerve field The regional distribution of nerve terminals.
(05 Mar 2000)
dark-field condenser An apparatus for throwing reflected light through the microscope field, so that only the object to be examined is illuminated, the field itself being dark.
(05 Mar 2000)
dark field illumination <microscopy> Any method of illumination which illuminates the specimen but does not admit light directly to the objective. It may be by substage (dark field) condensers, by stagespot lighting, by special condensers fitted around special objectives for reflected illumination or by the slit ultramicroscope.
(05 Aug 1998)
dark field imaging <microscopy> Using a single diffracted beam to form the image in a transmission electron microscope. This causes all regions of the specimen not of the same crystal structure and orientation as the region which produced the diffracted beam to be represented as very dark in the final image, allowing phase differentiation visually in the transmission electron microscope.
(05 Aug 1998)
dark-field microscope <instrument> A microscope that has a special condenser and objective with a diaphragm or stop that scatters light from the object observed, with the result that the object appears bright on a dark background.
(05 Mar 2000)
dark field microscopy <procedure> A system of microscopy in which particles are illuminated at a very low angle from the side so that the background appears dark and the objects are seen by diffracted and reflected patches of light against a dark background.
(18 Nov 1997)
dark field objective <microscopy> Certain objectives for high-power, dark fieldwork equipped with iris diaphragms or funnel stops so that their apertures may be reduced to correspond to the dark field con-denser with which they are used.
(05 Aug 1998)
dark field slides <microscopy> Owing to the exacting demands of dark field illumination, not only must the microscope slide be especially clean, but also the glass of which the slide is composed must be optically clear under dark field conditions. The glass should not fluoresce.
(05 Aug 1998)
dark field stop <microscopy> A central stop for obtaining a dark field effect for low-power objectives. It is customarily used with a high numerical aperture, bright field condenser.
(05 Aug 1998)
depth of field <microscopy> The depth or thickness of the object space that is simultaneously in acceptable focus.
The distance between the closest and farthest objects in focus within a scene as viewed by a lens at a particular focus and with given settings. The depth of field varies with the focal length of the lens and its f-stop setting or numerical aperture, and the wavelength of light. Depth of fields only a small fraction of a micrometre can be achieved at 546 nm with microscope lenses of N.A. Greater than 0.9.
(05 Aug 1998)
image field <microscopy> Any field showing a focused image. There are a number of such fields in the complete microscopical system. The term may also denote the field of view, or the image field at the focal plane of the camera, generally the field where the final image is formed.
(05 Aug 1998)
individuation field The field within which an organiser can bring about the rearrangement of primordial tissues in such a manner that a complete embryo is formed.
(05 Mar 2000)
object field <microscopy> A position lying in the front focal plane of the objective.
(05 Aug 1998)
electric field <radiobiology> A property of a patch of space which causes the acceleration of electric charges located at that patch of space.
The acceleration is given by a = qE/m, where q is the charge, E the electric field vector, and m the mass of the particle. Electric fields are generated by the presence of charges and/or the time variation of magnetic fields
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • focal point
    ÃÊÁ¡
  • four point stance
    4Á¡ ½ºÅĽº
  • freezing point
    ºùÁ¡
  • full point
    Á¾ÁöºÎ
  • fusion point
    À¶Á¡;¿ëÇØÁ¡
  • game point
    (Å״Ͻº µîÀÇ)°ÔÀÓ Æ÷ÀÎÆ®(ÇÑ °ÔÀÓÀÇ ½Â¸®¸¦ °áÁ¤ÇÏ´Â Á¡¼ö)
  • gold point
    Á¤È­ ¼ö¼ÛÁ¡
  • grade point
    (¹Ì)(¼ýÀÚ·Î ³ªÅ¸³½)¼ºÀû ÆòÁ¡
  • grade point average
    (¹Ì)¼ºÀûÀÇ Æò±ÕÁ¡
  • growing point
    »ýÀåÁ¡
  • high point
    Áß´ëÇÑ ½ÃÁ¡;ÃÖ°íÀÇ ½Ã±â
  • ice point
    ºùÁ¡
  • infection point
    º¯°îÁ¡
  • isolated point
    (¼ö)°í¸³Á¡
  • key point
    ¿äÃæ;¿äÁ¡;°ü°Ç !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á